Biogen Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 8.2B 9.8B 10.2B 11.0B
Cost of revenue 2.0B 2.5B 2.3B 2.1B
Gross profit 6.3B 7.3B 7.9B 8.9B
Operating expense
Research & development 1.7B 2.5B 2.2B 2.5B
Selling general and admin 2.0B 2.5B 2.4B 2.7B
Other operating expenses 216.8M 218.8M -7.4M 7.2M
Operating income 1.9B 1.8B 2.9B 2.8B
Non operating interest income
Income 57.6M 276.5M 89.3M 11M
Expense 213.3M 246.9M 246.6M 253.6M
Other income expense -111.0M -563.9M 847.2M -820.2M
Pretax income 1.6B 1.3B 3.6B 1.7B
Tax provision 233.3M 135.3M 632.8M 52.5M
Net income 1.4B 1.2B 3.0B 1.7B
Basic EPS 11.2 8.0 21.0 10.4
Diluted EPS 11.2 8.0 20.9 10.4
Basic average shares 124.1M 150.6M 151.2M 155.2M
Diluted average shares 124.1M 150.6M 151.2M 155.2M
EBITDA 2.6B 2.6B 3.5B 3.7B
Net income from continuing op. 1.4B 1.2B 3.0B 1.7B
Minority interests 0 -400K 85.3M -171.5M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 1 hour 14 minutes

06:45
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).